TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 1 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $166,000 | +18.6% | 123,912 | 0.0% | 0.00% | – |
Q4 2018 | $140,000 | -71.8% | 123,912 | -31.2% | 0.00% | – |
Q3 2018 | $496,000 | +52.6% | 180,010 | +98.0% | 0.00% | – |
Q2 2018 | $325,000 | +16.5% | 90,924 | 0.0% | 0.00% | – |
Q1 2018 | $279,000 | -51.3% | 90,924 | 0.0% | 0.00% | -100.0% |
Q4 2017 | $573,000 | +10.4% | 90,924 | +19.9% | 0.00% | 0.0% |
Q3 2017 | $519,000 | +8.4% | 75,863 | +13.0% | 0.00% | 0.0% |
Q2 2017 | $479,000 | -31.3% | 67,136 | -11.5% | 0.00% | 0.0% |
Q1 2017 | $697,000 | +127.8% | 75,844 | 0.0% | 0.00% | – |
Q4 2016 | $306,000 | +26.4% | 75,844 | +20.1% | 0.00% | – |
Q3 2016 | $242,000 | -4.3% | 63,153 | +7.2% | 0.00% | – |
Q2 2016 | $253,000 | -49.2% | 58,899 | -45.2% | 0.00% | -100.0% |
Q1 2016 | $498,000 | -51.3% | 107,573 | +5.5% | 0.00% | -50.0% |
Q4 2015 | $1,022,000 | +34.5% | 101,923 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $760,000 | -72.9% | 101,923 | +72.6% | 0.00% | -60.0% |
Q2 2015 | $2,801,000 | +82.4% | 59,036 | +40.9% | 0.01% | +66.7% |
Q1 2015 | $1,536,000 | +6.5% | 41,910 | +15.4% | 0.00% | 0.0% |
Q4 2014 | $1,442,000 | +134.5% | 36,319 | +17.9% | 0.00% | +200.0% |
Q3 2014 | $615,000 | +47.8% | 30,805 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $416,000 | +104.9% | 30,805 | +65.6% | 0.00% | – |
Q1 2014 | $203,000 | +1.5% | 18,605 | +25.8% | 0.00% | – |
Q4 2013 | $200,000 | +19.0% | 14,795 | 0.0% | 0.00% | – |
Q3 2013 | $168,000 | +60.0% | 14,795 | -0.6% | 0.00% | – |
Q2 2013 | $105,000 | – | 14,887 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 1,048,642 | $3,219,000 | 0.50% |
Virtus ETF Advisers LLC | 130,920 | $402,000 | 0.35% |
683 Capital Management, LLC | 600,000 | $1,842,000 | 0.16% |
Tekla Capital Management LLC | 859,322 | $2,638,000 | 0.10% |
DOW CHEMICAL CO /DE/ | 65,000 | $200,000 | 0.07% |
Alambic Investment Management, L.P. | 115,834 | $356,000 | 0.05% |
A.R.T. Advisors, LLC | 262,896 | $807,000 | 0.03% |
Candriam S.C.A. | 520,613 | $1,598,000 | 0.03% |
Man Group plc | 1,674,341 | $5,140,000 | 0.02% |
Baker Brothers Advisors | 935,000 | $2,870,000 | 0.02% |